Ilana Garcia-Grossman, MD, MAS
Assistant Professor
Medicine
School of Medicine

Ilana Garcia-Grossman, MD, MAS (she/hers) is an Assistant Professor of Medicine in the Department of General Internal Medicine at San Francisco General Hospital. She is the UCSF Residency Ambulatory Site Director and an Associate Medical Director at the Richard Fine People's Clinic. She is a primary care physician with interests including health equity, LGBTQ health, and correctional health.

Education & Training

Show all (4) Hide

• MAS Masters Degree in Clinical & Epidemiologic Research 2023
• National Clinician Scholars Program (NCSP), VA Scholar 2023
• Internal Medicine Residency, SFPC Primary Care Track 2021
• MD University of California, San Francisco

Interests

Show all (4) Hide

• Community Health
• Primary Care
• Quality Improvement
• Health Disparities

Publications (22)

Top publication keywords:
Diabetes MellitusHospital VolunteersPrisonsAnti-HIV AgentsLung DiseasesPre-Exposure ProphylaxisSubstance-Related DisordersInpatientsPrisonersCarcinoma, Transitional CellSocial IsolationUrotheliumCisplatinUrologic NeoplasmsCarboplatin

• Initiating pre-exposure prophylaxis in the inpatient setting: a quality improvement project.
  BMJ open quality 2024 Flynn S, Adamo M, Kochanska M, Garcia-Grossman I
• History of Incarceration and Its Association With Geriatric and Chronic Health Outcomes in Older Adulthood.
  JAMA network open 2023 Garcia-Grossman IR, Cenzer I, Steinman MA, Williams BA
• Public Health and Prisons: Priorities in the Age of Mass Incarceration.
  Annual review of public health 2022 Cloud DH, Garcia-Grossman IR, Armstrong A, Williams B
• Utilizing Inpatient Admissions to Increase HIV Screening During the COVID-19 Pandemic and Beyond.
  American journal of medical quality : the official journal of the American College of Medical Quality 2022 Garcia-Grossman I, Hauser K, Adamo M, Flynn S, Burbank S, Crawford C, Davis J, Lydon E, Reed G, Kochanska M, Guzman K
• Strategies for Addressing Vaccine Hesitancy Within California State Prisons in 2021 and Beyond.
  American journal of public health 2022 Garcia-Grossman IR, Gransee L, Williams B

Show all (17 more) Hide

• The Impact Of COVID-19 On The Health Of Incarcerated Older Adults In California State Prisons.
  Health affairs (Project Hope) 2022 Kwan A, Garcia-Grossman I, Sears D, Bertozzi SM, Williams BA
• Creating a Culture of Antiracism in an Internal Medicine Residency: Resident Physicians as Catalysts of Change.
  Academic medicine : journal of the Association of American Medical Colleges 2022 Choudhury A, Garcia-Grossman I, Martinez A
• A stepwise guide for healthcare professionals requesting compassionate release for patients who are incarcerated.
  International journal of prisoner health 2022 Kanbergs A, Garcia-Grossman I, Ahalt C, DiTomas M, Bedard R, Williams B
• Factors Associated with Incarceration in Older Adults Experiencing Homelessness: Results from the HOPE HOME Study.
  Journal of general internal medicine 2021 Garcia-Grossman I, Kaplan L, Valle K, Guzman D, Williams B, Kushel M
• Enabling patient communication for hospitalised patients during and beyond the COVID-19 pandemic.
  BMJ innovations 2021 Ganeshan S, Hsiang E, Peng T, Thomas N, Garcia-Grossman I, Javaherian K, Lyon Z, Vidyarthi A
• Rapid Implementation of a Volunteer-Run Service to Combat Social Isolation in Hospitalized Patients During the COVID-19 Pandemic.
  American journal of medical quality : the official journal of the American College of Medical Quality 2021 Lyon ZM, Yang R, Savoie MB, Schear S, Dong J, Javaherian K, Hauser K, Sarkar U, Garcia-Grossman I
• A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma.
  Cancer 2020 McPherson V, Reardon B, Bhayankara A, Scott SN, Boyd ME, Garcia-Grossman IR, Regazzi AM, McCoy AS, Kim PH, Al-Ahmadie H, Ostrovnaya I, Roth AJ, Farooki A, Berger MF, Rosenberg JE, Solit DB, Van Allen …
• Evaluating the association of multiple single nucleotide polymorphisms with response to gemcitabine and platinum combination chemotherapy in urothelial carcinoma of the bladder
.
  International journal of clinical pharmacology and therapeutics 2017 Alanee SR, Shah S, Zabor EC, Vijai J, Ostrovnaya I, Garcia-Grossman IR, Pendse DV, Littman J, Regazzi AM, Offit K, Bajorin DF
• Outcome and Impact Evaluation of a Transgender Health Course for Health Profession Students.
  LGBT health 2017 Braun HM, Garcia-Grossman IR, Quiñones-Rivera A, Deutsch MB
• Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.
  Clinical genitourinary cancer 2016 O'Donnell PH, Alanee S, Stratton KL, Garcia-Grossman IR, Cao H, Ostrovnaya I, Plimack ER, Manschreck C, Ganshert C, Smith ND, Steinberg GD, Vijai J, Offit K, Stadler WM, Bajorin DF
• The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: a large single-institution experience.
  The oncologist 2015 Bambury RM, Benjamin DJ, Chaim JL, Zabor EC, Sullivan J, Garcia-Grossman IR, Regazzi AM, Ostrovnaya I, Apollo A, Xiao H, Voss MH, Iyer G, Bajorin DF, Rosenberg JE
• Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma.
  Cancer discovery 2014 Van Allen EM, Mouw KW, Kim P, Iyer G, Wagle N, Al-Ahmadie H, Zhu C, Ostrovnaya I, Kryukov GV, O'Connor KW, Sfakianos J, Garcia-Grossman I, Kim J, Guancial EA, Bambury R, Bahl S, Gupta N, Farlow D, Qu …
• Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host.
  Annals of oncology : official journal of the European Society for Medical Oncology 2013 Gallagher DJ, Vijai J, Hamilton RJ, Ostrovnaya I, Iyer G, Garcia-Grossman IR, Kim PH, Przybylo JA, Alanee S, Riches JC, Regazzi AM, Milowsky MI, Offit K, Bajorin DF
• Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Iyer G, Al-Ahmadie H, Schultz N, Hanrahan AJ, Ostrovnaya I, Balar AV, Kim PH, Lin O, Weinhold N, Sander C, Zabor EC, Janakiraman M, Garcia-Grossman IR, Heguy A, Viale A, Bochner BH, Reuter VE, Bajorin…
• Phase II study of everolimus in metastatic urothelial cancer.
  BJU international 2013 Milowsky MI, Iyer G, Regazzi AM, Al-Ahmadie H, Gerst SR, Ostrovnaya I, Gellert LL, Kaplan R, Garcia-Grossman IR, Pendse D, Balar AV, Flaherty AM, Trout A, Solit DB, Bajorin DF
• Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Balar AV, Apolo AB, Ostrovnaya I, Mironov S, Iasonos A, Trout A, Regazzi AM, Garcia-Grossman IR, Gallagher DJ, Milowsky MI, Bajorin DF
• Sunitinib in urothelial cancer: clinical, pharmacokinetic, and immunohistochemical study of predictors of response.
  European urology 2011 Gallagher DJ, Al-Ahmadie H, Ostrovnaya I, Gerst SR, Regazzi A, Garcia-Grossman I, Riches J, Gounder SK, Flaherty AM, Trout A, Milowsky MI, Bajorin DF